Karuna Therapeutics, Inc. (KRTX) Social Stream
Karuna Therapeutics Inc (KRTX) Price Targets From Analysts
Use the tables below to see what analysts covering Karuna Therapeutics Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 22 months, KRTX's average price target has gone up $48.13.
Over the past 51 weeks, KRTX's average upside potential has been 38.22%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
KRTX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 23 months, KRTX's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how Karuna Therapeutics Inc fares relative to stocks in the mid market cap category, note that its average analyst price target is higher than 948.99% of that group.
- In the context of Pharmaceutical Products stocks, Karuna Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 131.41% of them.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, Karuna Therapeutics Inc's number of analysts covering the stock is greater than 862.42% of them.
- In terms of how Karuna Therapeutics Inc fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -50.61% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Karuna Therapeutics Inc are KDNY, ITCI, and ISEE.
Is KRTX a Buy, Hold or Sell? See the POWR Ratings now!